美国胃肠道疾病阿片类药物处方率持续上升
该研究基于2006至2016年美国门诊医疗调查数据,分析以胃肠道诊断为主的门诊就诊中阿片类处方趋势。结果显示胃肠道就诊阿片类处方率为10.1%,且每年增加0.5%,慢性胰腺炎和慢性肝病处方率最高,多数为续方。
要点
- 胃肠道疾病门诊阿片类处方率10.1%,2006至2016年每年增0.5%。
- 慢性胰腺炎(25.1%)和慢性肝病(13.9%)处方率最高。
核心结论
- 2006至2016年美国胃肠道疾病门诊阿片类处方率呈上升趋势,提示对阿片危机的应对不足。
主要发现
- 胃肠道就诊阿片类处方率为10.1%(95%CI 9.0%-11.2%)。
- 2006至2016年胃肠道疾病阿片类处方率每年增加0.5%(P=0.04)。
- 慢性胰腺炎(25.1%)和慢性肝病(13.9%)就诊处方率最高。
- 与续方相关的患者因素包括农村地区(aOR 1.46;95%CI 1.11-1.93)、抑郁(aOR 1.83;95%CI 1.33-2.53)和医疗补助保险(aOR 1.57;95%CI 1.15-2.13)。
临床怎么用
- 消化内科医生应关注胃肠道疾病患者的阿片类处方,尤其是慢性胰腺炎和慢性肝病患者。
- 对农村、抑郁或医疗补助保险患者续方时应加强评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pain control is an important management approach for many gastrointestinal conditions. Because of the ongoing opioid crisis, public health efforts have focused on limiting opioid prescriptions. This study examines national opioid prescribing patterns and factors associated with opioid prescriptions for gastrointestinal conditions. METHODS: We conducted a repeated cross-sectional study using the National Ambulatory Medical Care Survey data from 2006 to 2016. The International Classification of Diseases codes were used to identify ambulatory visits with a primary gastrointestinal diagnosis. Data were weighted to calculate national estimates for opioid prescriptions for gastrointestinal disease. Joinpoint regression was used to analyze temporal trends. Multivariable logistic regression was used to examine factors associated with opioid prescriptions. RESULTS: We analyzed 12,170 visits with a primary gastrointestinal diagnosis, representing 351 million visits. The opioid prescription rate for gastrointestinal visits was 10.1% (95% confidence interval [CI] 9.0%-11.2%). Opioid prescription rates for gastrointestinal disease increased by 0.5% per year from 2006 to 2016 (P = 0.04). Prescription rates were highest for chronic pancreatitis (25.1%) and chronic liver disease (13.9%) visits. Seventy-one percent of opioid prescriptions were continuations of an existing prescription. Patient characteristics associated with continued opioid prescriptions included rural location (adjusted odds ratio [aOR] 1.46; 95% CI 1.11-1.93), depression (aOR 1.83; 95% CI 1.33-2.53), and Medicaid insurance (aOR 1.57; 95% CI 1.15-2.13). DISCUSSION: Opioid prescription rates for gastrointestinal disease visits increased from 2006 to 2016. Our findings suggest an inadequate response to the opioid epidemic by providers managing gastrointestinal conditions. Further clinical interventions are needed to limit opioid use for gastrointestinal disease.(Equation is included in full-text article.).
引用
- LeBrett WG, Chen FW, Yang L, et al. Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. Am J Gastroenterol. 2021. PMID: 33982950. doi:10.14309/ajg.0000000000001052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。